ATE420364T1 - Verfahren zur magenkrebsvorhersage - Google Patents

Verfahren zur magenkrebsvorhersage

Info

Publication number
ATE420364T1
ATE420364T1 AT02700861T AT02700861T ATE420364T1 AT E420364 T1 ATE420364 T1 AT E420364T1 AT 02700861 T AT02700861 T AT 02700861T AT 02700861 T AT02700861 T AT 02700861T AT E420364 T1 ATE420364 T1 AT E420364T1
Authority
AT
Austria
Prior art keywords
cancer
concentration
galectin
contracting
predicting
Prior art date
Application number
AT02700861T
Other languages
English (en)
Inventor
Hee-Jong Woo
Original Assignee
Zarita Biotech Co Ltd
Hee-Jong Woo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zarita Biotech Co Ltd, Hee-Jong Woo filed Critical Zarita Biotech Co Ltd
Application granted granted Critical
Publication of ATE420364T1 publication Critical patent/ATE420364T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/57585—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds identifiable in body fluids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02700861T 2000-10-30 2002-02-19 Verfahren zur magenkrebsvorhersage ATE420364T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0063868A KR100395254B1 (ko) 2000-10-30 2000-10-30 종양 발생 예측 키트
PCT/KR2002/000249 WO2003071279A1 (en) 2000-10-30 2002-02-19 Method and kit for predicting cancer

Publications (1)

Publication Number Publication Date
ATE420364T1 true ATE420364T1 (de) 2009-01-15

Family

ID=29422485

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02700861T ATE420364T1 (de) 2000-10-30 2002-02-19 Verfahren zur magenkrebsvorhersage

Country Status (7)

Country Link
US (2) US20020076738A1 (de)
EP (1) EP1476757B1 (de)
KR (1) KR100395254B1 (de)
CN (1) CN1325917C (de)
AT (1) ATE420364T1 (de)
AU (1) AU2002233800A1 (de)
WO (1) WO2003071279A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257946A1 (en) * 2003-06-06 2006-11-16 Ciphergen Biosystems, Inc Serum biomarkers in ischaemic heart disease
AU2012244071B2 (en) * 2003-10-09 2014-12-04 Universiteit Maastricht Method for identifying a subject at risk of developing heart failure by determining the level of galectin-3 or thrombospondin-2
EP1522857A1 (de) * 2003-10-09 2005-04-13 Universiteit Maastricht Methode zur Feststellung des Risikos von Herzversagen in einem Individuum durch Bestimmung der Menge an Galectin-3 oder Thrombospondin-2
BRPI0919975A2 (pt) * 2008-10-29 2015-12-15 Bg Medicine Inc imunoensaio para galectina-3
EP3115063A3 (de) * 2008-12-03 2017-04-19 The John Hopkins University Galektin-3 und annexin a2 als immunologisches zielmolekül
KR101343035B1 (ko) 2008-12-22 2013-12-18 삼성전자 주식회사 제1수용체, 차단물질 및 제2수용체가 고정화된 고체 기판을포함하는 표적물질을 분석하기 위한 물품 및 그 용도
JP5702386B2 (ja) * 2009-08-25 2015-04-15 ビージー メディシン， インコーポレイテッド ガレクチン−３および心臓再同期療法
CN103487588B (zh) * 2013-09-18 2015-01-14 福建医科大学附属第一医院 Galectin-4蛋白在制备巨大肝癌术后预后评估试剂盒中的应用
WO2016024627A1 (ja) * 2014-08-14 2016-02-18 国立大学法人広島大学 早産および／または低体重児出産のリスク判定方法およびそのためのキット
JP7368856B2 (ja) 2017-07-25 2023-10-25 トゥルーバインディング，インコーポレイテッド Ｔｉｍ－３とそのリガンドとの相互作用の遮断によるがん治療
CN120058944A (zh) 2019-01-30 2025-05-30 真和制药有限公司 抗gal3抗体及其用途
CN111505304A (zh) * 2019-01-31 2020-08-07 艾维可生物科技有限公司 一种化学发光法检测半乳糖凝集素-3的试剂盒及使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5801002A (en) * 1989-01-06 1998-09-01 Barbara Ann Karmanos Cancer Institute Galactoside-binding-protein useful in the diagnosis and inhibition of of metastasis
US5869289A (en) * 1996-10-09 1999-02-09 Incyte Pharmaceuticals, Inc. Human galectin homolog
US5837493A (en) * 1997-01-23 1998-11-17 Incyte Pharmaceuticals, Inc. Human galectins
US6146849A (en) * 1998-06-04 2000-11-14 University Of Georgia Research Foundation Inc. Lectins and coding sequences
US6699722B2 (en) * 2000-04-14 2004-03-02 A-Fem Medical Corporation Positive detection lateral-flow apparatus and method for small and large analytes

Also Published As

Publication number Publication date
CN1325917C (zh) 2007-07-11
EP1476757A4 (de) 2006-04-26
US20050084915A1 (en) 2005-04-21
WO2003071279A1 (en) 2003-08-28
KR100395254B1 (ko) 2003-08-21
EP1476757B1 (de) 2009-01-07
AU2002233800A1 (en) 2003-09-09
US20020076738A1 (en) 2002-06-20
EP1476757A1 (de) 2004-11-17
CN1620612A (zh) 2005-05-25
KR20020033246A (ko) 2002-05-06

Similar Documents

Publication Publication Date Title
Poole et al. The assessment of cartilage degradation in vivo: development of an immunoassay for the measurement in body fluids of type II collagen cleaved by collagenases
Ogawa et al. Wisteria floribunda agglutinin‐positive Mac‐2‐binding protein and type 4 collagen 7S: useful markers for the diagnosis of significant fibrosis in patients with non‐alcoholic fatty liver disease
RU2262706C2 (ru) Способ для диагностики атрофических гастритов
DE60228557D1 (de) Candida-nachweis
CN105556308B (zh) 用于阑尾炎的诊断和预后及腹痛病因的区分的方法和组合物
ATE411525T1 (de) Nachweis einer histonmodifikation in zellfreien nukleosomen
DE60233744D1 (de) Bestimmung der zirkulierenden therapeutischen antikörper, antigene sowie antigen-antikörper-komplexe mit elisa-tests
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
WO2005108989A3 (en) Assay for antibodies
CY1107859T1 (el) Μεθοδος για διαγνωση πολλαπλης σκληρυνσης
KR20120057562A (ko) 피브린 및 피브리노겐 분해 생성물의 검출 및 관련된 제조 방법 및 암의 검출 및 모니터링을 위한 용도
RU2020127440A (ru) Способы, применения и наборы для диагностики заболеваний периодонта
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
EP3472199B1 (de) Comp-peptid und antikörper dafür zur diagnose von osteoarthritis
DE60025170D1 (de) Diagnostisches verfahren für asthma
KR102372675B1 (ko) 치주 질환 진단용 마커 단백질을 검출하는 방법
KR102802482B1 (ko) 치주질환 진단 방법, 이를 위한 조성물 및 키트
ATE493662T1 (de) Diagnostischer test für menschliches matrix gla- protein und seine verwendung als biomarker
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
EP1636587A4 (de) Einen für menschliches protoonkogenes protein spezifischen antikörper enthaltender diagnostischer kit für leberzirrhose
JP5339227B2 (ja) アクロレイン、インターロイキン−６及びｃｒｐの含有量、ポリアミンオキシダーゼ活性又はポリアミンオキシダーゼの蛋白質量、並びに、被験者の年齢を指標とした脳卒中・無症候性脳梗塞の検出方法
WO2016205740A1 (en) Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain
Kang et al. Near real-time immuno-optical sensor for diagnosing single point mutation: A model system: Sensor for factor V Leiden diagnosis
DE50304756D1 (de) Verfaren zur diagnose von neoplasmen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties